Theoretical model for the interpretation of BMD scans in patients stopping strontium ranelate treatment

被引:20
作者
Blake, Glen M. [1 ]
Fogelman, Ignac [1 ]
机构
[1] Guys Hosp, Dept Nucl Med, London SE1 9RT, England
关键词
BMD; strontium ranelate; osteoporosis treatment;
D O I
10.1359/JBMR.060616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The oral administration of strontium ranelate causes a clinically significant overestimation of BMD because of the high attenuation of X-rays by strontium atoms in bone. As more patients are treated with strontium ranelate, questions will arise about the correct interpretation of their future BMD measurements. We performed a theoretical study to calculate the long-term effect of strontium treatment on BMD and establish the duration of past treatment for which the remaining bone strontium content (BSC) has a negligible effect on BMD. Materials and Methods: The BMD changes measured at the spine and hip during strontium ranelate treatment were interpolated from clinical trial data. The long-term retention of strontium in bone was estimated using the International Commission on Radiological Protection (ICRP) strontium retention function modified for use in postmenopausal women. Estimates of the strontium BMD artefact after treatment has stopped were performed on the assumption that the BSC effect accounts for 75% of the total measured BMD change at 3 years. Results: If 75% of the BMD changes are explained by BSC, in the average patient, 3-year treatment leads to a spine BMD artefact of 11.2%, decreasing to 3.8% 10 years after stopping treatment. The BMD artefacts at the total hip and femoral neck sites are smaller by factors of 0.65 and 0.53, respectively. If pre- and post-therapy BMD measurements are available, these predictions can be tailored to the individual patient. On average, 6-month treatment is required for the spine BMD artefact to exceed 3%, the figure adopted as the maximum BMD change caused by bone strontium that has a negligible effect on scan interpretation. Ten years after stopping treatment, 28 months of treatment are required for the residual BMD artefact to still exceed the 3% threshold. Conclusions: Strontium ranelate treatment lasting for > 6 months can affect BMD measurements for many years afterward.
引用
收藏
页码:1417 / 1424
页数:8
相关论文
共 28 条
[1]   Absorption of strontium from the gastrointestinal tract into plasma in healthy human adults [J].
Apostoaei, AI .
HEALTH PHYSICS, 2002, 83 (01) :56-65
[2]  
Arlot ME, 2005, J BONE MINER RES, V20, pS22
[3]   EXCRETION AND RETENTION OF RADIOACTIVE STRONTIUM IN NORMAL MEN FOLLOWING A SINGLE INTRAVENOUS INJECTION [J].
BISHOP, M ;
HARRISON, GE ;
RAYMOND, WHA ;
SUTTON, A ;
RUNDO, J .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY AND RELATED STUDIES IN PHYSICS CHEMISTRY AND MEDICINE, 1960, 2 (02) :125-142
[4]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]   Long-term effect of strontium ranelate treatment on BMD [J].
Blake, GM ;
Fogelman, G .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (11) :1901-1904
[6]   TURNOVER OF STRONTIUM-85 IN MAN AS DETERMINED BY WHOLE-BODY COUNTING [J].
COHN, SH ;
SAMACHSON, J ;
SPENCER, H ;
ROBERTSON, JS .
RADIATION RESEARCH, 1962, 17 (02) :173-&
[7]   Incorporation and distribution of strontium in bone [J].
Dahl, SG ;
Allain, P ;
Marie, PJ ;
Mauras, Y ;
Boivin, G ;
Ammann, P ;
Tsouderos, Y ;
Delmas, PD ;
Christiansen, C .
BONE, 2001, 28 (04) :446-453
[8]   Treatment of postmenopausal osteoporosis [J].
Eastell, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :736-746
[9]   Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].
Ettinger, B ;
Black, DM ;
Mitlak, BH ;
Knickerbocker, RK ;
Nickelsen, T ;
Genant, HK ;
Christiansen, C ;
Delmas, PD ;
Zanchetta, JR ;
Stakkestad, J ;
Glüer, CC ;
Krueger, K ;
Cohen, FJ ;
Eckert, S ;
Ensrud, KE ;
Avioli, LV ;
Lips, P ;
Cummings, SR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645
[10]   Monitoring skeletal changes by radiological techniques [J].
Glüer, CC .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (11) :1952-1962